IGFBP7 and acute kidney injury: IGFBP7 has been proposed as a biomarker for acute kidney injury (AKI), aiming to enhance early detection, discrimination, and prognosis assessment, complementing serum creatinine and urine output (Meena et al., 2023; Murugan et al., 2023; Stanski et al., 2023).